Continuous Glucose Monitoring Market Size to Reach US$ 9.56 Billion by 2027, Growing at a CAGR of 9.50% | IMARC Group

Continuous Glucose Monitoring Market Overview:

The latest research study "Continuous Glucose Monitoring Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global continuous glucose monitoring systems market size reached a value of US$ 5.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 9.56 Billion by 2027, exhibiting a CAGR of 9.50% during 2022-2027.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/continuous-glucose-monitoring-systems-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Continuous glucose monitoring systems (CGMS) are advanced glucose sensing and monitoring devices that measure, track and display the blood glucose levels of a patient. They consist of a glucose sensor inserted into the subcutaneous tissue that continuously measures the glucose concentration in the interstitial fluid or blood. They also have a transmitter attached to the sensor that transfers the data to a receiver, a wireless monitor, or a smartphone. These systems assist in providing a complete profile of diabetes, detecting patterns, and alerting highs and lows of blood sugar levels. As a result, CGMS is gaining traction over conventional glucose monitoring devices.

Continuous Glucose Monitoring Systems Market Trends and Drivers:

The market is primarily driven by the increasing geriatric population that is more susceptible to diabetes. In addition, the extensive product utilization for identifying hyperglycemic and hypoglycemia situations in real-time is contributing to the market growth.

Besides this, advancements in CGMS technology that help detect glycated hemoglobin (Hb1ac) in diabetic patients are also positively impacting market growth.

Moreover, the integration of artificial pancreas device systems with CGMS technology for pumping insulin and administering optimum dosage to manage the blood sugar level of patients and the escalating demand for less or minimally invasive diagnostic tools are creating a positive outlook for the market.

Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5377&flag=F

Global Continuous Glucose Monitoring Systems Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

A. Menarini Diagnostics S.r.l., Abbott Laboratories, DexCom Inc., F. Hoffmann-La Roche AG, Glysens Incorporated, LifeScan Inc. (Johnson & Johnson), Medtronic PLC, Medtrum Technologies Inc., Nemaura Medical Inc., Novo Nordisk A/S, Senseonics Holdings Inc. and Waveform Technologies Inc.

The report has segmented the market on the basis of region, component, demographics and end user.

Breakup by Component:
• Sensors
• Transmitters and Receivers
• Integrated Insulin Pumps

Breakup by Demographics:
• Child Population (≤14 years)
• Adult Population (>14 years)

Breakup by End User:
• Clinics and Diagnostics Centers
• ICUs
• Home Healthcare

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/continuous-glucose-monitoring-systems-market

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Other Research Report of IMARC Group:

Operating Room Equipment Market Report 2022-2027: https://www.imarcgroup.com/operating-room-equipment-market

Compression Stockings Market Report 2022-2027: https://www.imarcgroup.com/compression-stockings-market

Neurology Devices Market Report 2022-2027: https://www.imarcgroup.com/neurology-devices-market

Orthodontics Market Report 2022-2027: https://www.imarcgroup.com/orthodontics-market

Prostate Cancer Treatment Market Report 2022-2027: https://www.imarcgroup.com/prostate-cancer-treatment-market

Ophthalmic Devices Market Report 2022-2027: https://www.imarcgroup.com/ophthalmic-devices-market

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.